COUGH MEDICATION

Brand Owner (click to sort) Address Description
2/G AVENTIS INC. 3711 Kennett Pike, Suite 200 Greenville DE 19807 COUGH MEDICATION;2 G;
CAPSIONEX MALLINCKRODT INC. 675 McDonnell Blvd. P.O. Box 5840 St. Louis MO 63134 Cough medication; expectorant;
CODICLEAR VICTORY PHARMA, INC. 11682 El Camino Real Suite 250 San Diego CA 92130 COUGH MEDICATION;CODEINE CLEAR;
KURB RICHARDSON-MERRELL INC. Wilton CT COUGH MEDICATION;CURB;
SIMPLY COUGH Johnson & Johnson One Johnson & Johnson Plaza New Brunswick NJ 08933 cough medication;COUGH;
SNAPLETS-DM BAKER CUMMINS PHARMACEUTICALS, INC. 8800 N.W. 36TH ST. MIAMI FL 33178 cough medication;
SUDAFED Johnson & Johnson One Johnson & Johnson Plaza New Brunswick NJ 08933 Cough Medication;
TUSSACTIN MALLINCKRODT INC. 675 McDonnell Blvd. P.O. Box 5840 St. Louis MO 63134 Cough medication; expectorant;
TUSSEND Merrell Dow Pharmaceuticals Inc. Cincinnati OH COUGH MEDICATION;
TUSSIBRON FELTREX, S.A. Roberto Pastoriza No. 654 Santo Domingo, R.D Dominican Rep cough medication;
TUSSIPEL MALLINCKRODT INC. 675 McDonnell Blvd. P.O. Box 5840 St. Louis MO 63134 Cough medication; expectorant;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides systems and methods for monitoring subjects, especially during sleep. Respiratory and sound data are recorded and coughs arousal are recognized as joint events in both of these signals having selected characteristics. Further, cough-arousal events during sleep are recognized when a likely cough occurs in association with a recognized EEG arousal. Cough arousal events are combined into a cough arousal index that reflects disease severity and sleep disruption due to cough. The methods of this invention are computer-implemented and can be provided as a program product including a computer readable medium. Measurements and indices provided by this invention can be used to monitor and to treat respiratory diseases.